A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
D000096:Acetone / Q000652:urine; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D003510:Cyclohexanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy; D004351:Drug Resistance; D005260:Female; D006029:Glycosuria / Q000175:diagnosis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014044:Tolbutamide / Q000627:therapeutic use
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D011719:Pyrazines; D013453:Sulfonylurea Compounds; D000096:Acetone; D014044:Tolbutamide